The TAUSSIG trial will measure the longer\term efficacy and safety of evolocumab given Q2W or Q4W on LDL\C amounts at 5 years
The TAUSSIG trial will measure the longer\term efficacy and safety of evolocumab given Q2W or Q4W on LDL\C amounts at 5 years.79 Outcomes Studies Within a post hoc protection analysis…